A new Ebola vaccine trial has been launched in the Democratic Republic of Congo, marking another step in efforts to control the deadly virus.
The trial will evaluate the vaccine’s safety and effectiveness in the communities most at risk, building on the progress made with earlier vaccines used during recent outbreaks.
Ebola remains a serious public health concern in central Africa, where outbreaks have occurred periodically. Vaccination has become a central tool in the response, helping to slow transmission when cases emerge.
The new trial reflects continued investment in tools to prevent future outbreaks and reduce the burden on health systems.
Health officials say the results will help determine how the vaccine can be used most effectively in outbreak settings.
